HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rudolf Valenta Selected Research

Seasonal Allergic Rhinitis (Hay Fever)

1/2021Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1.
9/2020Quantification, epitope mapping and genotype cross-reactivity of hepatitis B preS-specific antibodies in subjects vaccinated with different dosage regimens of BM32.
1/2020Sensitization to grass pollen allergen molecules in a birth cohort-natural Phl p 4 as an early indicator of grass pollen allergy.
12/2019Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG4 response.
10/2019Expression and characterization of recombinant Par j 1 and Par j 2 resembling the allergenic epitopes of Parietaria judaica pollen.
1/2019Detection of genuine grass pollen sensitization in children by skin testing with a recombinant grass pollen hybrid.
1/2018Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32.
1/2018Grass-Allergic Children Frequently Show Asymptomatic Low-Level IgE Co-Sensitization and Cross-Reactivity to Wheat.
11/2017Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope-based grass pollen allergy vaccine with allergen extract-based vaccines.
1/2017Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rudolf Valenta Research Topics

Disease

166Hypersensitivity (Allergy)
10/2022 - 01/2002
42Asthma (Bronchial Asthma)
10/2022 - 01/2002
42Seasonal Allergic Rhinitis (Hay Fever)
01/2021 - 01/2002
37Inflammation (Inflammations)
01/2022 - 09/2003
23Infections
11/2022 - 05/2009
22Atopic Dermatitis (Atopic Eczema)
01/2022 - 04/2002
14Food Hypersensitivity (Food Allergy)
01/2021 - 05/2002
10COVID-19
11/2022 - 01/2020
10Anaphylaxis (Anaphylactic Shock)
01/2021 - 03/2004
8Rhinitis
06/2022 - 05/2015
8Hepatitis B
05/2022 - 06/2011
6Leukemia
01/2022 - 02/2007
5Communicable Diseases (Infectious Diseases)
01/2020 - 03/2002
5Allergic Rhinitis
05/2015 - 02/2007
4Conjunctivitis
06/2022 - 01/2006
4Dust Mite Allergy
01/2016 - 01/2008
3Celiac Disease (Celiac Sprue)
02/2022 - 10/2013
3Respiratory Sounds (Crackle)
01/2021 - 01/2018
3Nasal Polyps (Nasal Polyp)
01/2021 - 01/2016
3Immune System Diseases (Immune Disorders)
01/2021 - 05/2016
3Respiratory Tract Diseases (Respiratory Tract Disease)
06/2020 - 05/2009
3Milk Hypersensitivity (Milk Allergy)
06/2019 - 06/2009
3Wheat Hypersensitivity (Wheat Allergy)
01/2018 - 01/2009
3Skin Diseases (Skin Disease)
08/2017 - 05/2004
3Neoplasms (Cancer)
12/2005 - 01/2003
2Dermatitis
06/2022 - 09/2013
2Peanut Hypersensitivity (Peanut Allergy)
01/2021 - 01/2017
2Urticaria (Hives)
01/2020 - 02/2007
2Eczema
01/2017 - 01/2017
2Parasitic Diseases (Parasitic Disease)
01/2016 - 01/2003
2HIV Infections (HIV Infection)
01/2015 - 01/2014
2Skin Manifestations
01/2014 - 10/2002
2Virus Diseases (Viral Diseases)
01/2011 - 05/2009

Drug/Important Bio-Agent (IBA)

175AllergensIBA
10/2022 - 01/2002
152Immunoglobulin E (IgE)IBA
10/2022 - 01/2002
60VaccinesIBA
11/2022 - 01/2002
38AntibodiesIBA
05/2022 - 01/2002
35Immunoglobulin G (IgG)IBA
10/2022 - 08/2002
34Peptides (Polypeptides)IBA
11/2022 - 12/2004
27Proteins (Proteins, Gene)FDA Link
06/2022 - 08/2004
24AntigensIBA
11/2022 - 03/2002
20EpitopesIBA
10/2022 - 05/2004
10P-2 (P 2)IBA
01/2019 - 01/2002
8CytokinesIBA
11/2022 - 05/2004
7Biomarkers (Surrogate Marker)IBA
06/2022 - 04/2012
6Biological ProductsIBA
01/2022 - 03/2005
6Immunoglobulin A (IgA)IBA
12/2021 - 11/2005
5Recombinant Fusion ProteinsIBA
05/2022 - 04/2013
5Carrier Proteins (Binding Protein)IBA
05/2022 - 05/2009
5ParvalbuminsIBA
06/2017 - 05/2002
5AutoantibodiesIBA
09/2008 - 04/2002
4Pharmaceutical PreparationsIBA
02/2022 - 01/2012
4Membrane Proteins (Integral Membrane Proteins)IBA
09/2020 - 05/2009
4VenomsIBA
02/2020 - 06/2010
4B-Lymphocyte Epitopes (B-Cell Epitope)IBA
11/2017 - 05/2005
4Complementary DNA (cDNA)IBA
01/2014 - 07/2005
4CalciumIBA
09/2013 - 02/2002
4AutoantigensIBA
03/2009 - 10/2002
3CarbohydratesIBA
07/2022 - 04/2011
3InterferonsIBA
01/2021 - 01/2018
3Blocking AntibodiesIBA
06/2017 - 09/2003
3Antigen-Antibody Complex (Immune Complex)IBA
03/2017 - 03/2009
3Pyridinolcarbamate (P23)IBA
01/2017 - 04/2013
3Interleukin-4 (Interleukin 4)IBA
01/2017 - 08/2005
3Recombinant DNA (Recombinant DNA Research)IBA
02/2016 - 04/2011
3Combined VaccinesIBA
08/2012 - 08/2002
3Peptide Hydrolases (Proteases)FDA Link
03/2009 - 05/2006
2ragweed pollenIBA
07/2022 - 01/2018
2Glutens (Glutelin)IBA
02/2022 - 12/2015
2GliadinIBA
02/2022 - 12/2015
2Fibronectins (Fibronectin)IBA
01/2022 - 07/2011
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2021 - 01/2014
2Indicators and Reagents (Reagents)IBA
01/2020 - 10/2003
2Monoclonal AntibodiesIBA
01/2020 - 06/2006
2Immunoglobulins (Immunoglobulin)IBA
05/2018 - 09/2013
2Wasp Venoms (Venom, Wasp)IBA
01/2018 - 06/2010
2Adrenal Cortex Hormones (Corticosteroids)IBA
03/2017 - 01/2015
2APTIBA
01/2017 - 02/2016
2Dermatophagoides pteronyssinus antigen p 1IBA
01/2017 - 08/2012
2T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
02/2016 - 11/2010
2Synthetic Vaccines (Recombinant Vaccines)IBA
02/2016 - 04/2007
2ProteomeIBA
03/2015 - 01/2015
2purothioninIBA
01/2014 - 10/2013
2Dermatophagoides pteronyssinus antigen p 2IBA
08/2012 - 05/2008
2Aligeron (AS 2)IBA
06/2010 - 08/2004
2nascent-polypeptide-associated complexIBA
06/2008 - 10/2002
2Tryptases (Tryptase)IBA
01/2008 - 05/2006
2DNA VaccinesIBA
09/2006 - 01/2003
1Interleukin-13IBA
11/2022
1Tetanus Toxoid (Vaccine, Tetanus)FDA Link
11/2022
1Interleukin-2 (IL2)IBA
11/2022
1Enterotoxins (Enterotoxin)IBA
11/2022
1PhytohemagglutininsIBA
11/2022
1Protein Subunit VaccinesIBA
10/2022
1Protein Isoforms (Isoforms)IBA
07/2022
1Capsid Proteins (Capsid Protein)IBA
05/2022

Therapy/Procedure

61Immunotherapy
10/2022 - 01/2002
24Therapeutics
02/2022 - 02/2002
3Precision Medicine
01/2020 - 08/2017
2Cell- and Tissue-Based Therapy (Cell Therapy)
05/2016 - 01/2011